ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,688,000 | +61.0% | 82,718 | +3.2% | 0.01% | +50.0% |
| Q3 2021 | $4,774,000 | -17.0% | 80,171 | -4.9% | 0.01% | -14.3% |
| Q2 2021 | $5,750,000 | -5.5% | 84,317 | -3.8% | 0.01% | -12.5% |
| Q1 2021 | $6,084,000 | -10.1% | 87,677 | -0.4% | 0.01% | -11.1% |
| Q4 2020 | $6,765,000 | +2.8% | 88,049 | +0.0% | 0.01% | -18.2% |
| Q3 2020 | $6,582,000 | +23.1% | 88,006 | +3.6% | 0.01% | +22.2% |
| Q2 2020 | $5,345,000 | +65.8% | 84,912 | +10.6% | 0.01% | +28.6% |
| Q1 2020 | $3,224,000 | -8.0% | 76,758 | -0.5% | 0.01% | +16.7% |
| Q4 2019 | $3,504,000 | -1.7% | 77,138 | -0.9% | 0.01% | -14.3% |
| Q3 2019 | $3,563,000 | -21.0% | 77,854 | +1.2% | 0.01% | -22.2% |
| Q2 2019 | $4,510,000 | +32.4% | 76,924 | +1.2% | 0.01% | +28.6% |
| Q1 2019 | $3,407,000 | +12.6% | 76,008 | -2.2% | 0.01% | 0.0% |
| Q4 2018 | $3,026,000 | -13.2% | 77,698 | +2.5% | 0.01% | 0.0% |
| Q3 2018 | $3,487,000 | +5.3% | 75,776 | -0.3% | 0.01% | 0.0% |
| Q2 2018 | $3,312,000 | +14.9% | 75,973 | +4.1% | 0.01% | +16.7% |
| Q1 2018 | $2,883,000 | +36.9% | 72,984 | +17.7% | 0.01% | +50.0% |
| Q4 2017 | $2,106,000 | +31.2% | 61,983 | -1.5% | 0.00% | 0.0% |
| Q3 2017 | $1,605,000 | +67.5% | 62,932 | +10.8% | 0.00% | +100.0% |
| Q2 2017 | $958,000 | – | 56,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |